{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T13:05:50Z","timestamp":1768568750534,"version":"3.49.0"},"posted":{"date-parts":[[2025,3,11]]},"group-title":"Epidemiology","reference-count":32,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,3,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Mass oral cholera vaccination campaigns targeted at subnational areas with high incidence are central to global cholera elimination efforts. Serological surveillance offers a complementary approach to address gaps in clinical surveillance in these regions. However, similar immune responses from vaccination and infection can lead to overestimates of incidence of infection. To address this, we analyzed antibody dynamics in infected and vaccinated individuals to refine seroincidence estimation strategies for partially vaccinated populations. We tested 757 longitudinal serum samples from confirmed\n                  <jats:italic>Vibrio cholerae<\/jats:italic>\n                  O1 cases and uninfected contacts in Bangladesh as well as vaccinees from Bangladesh and Haiti, using a multiplex bead assay to measure IgG, IgM, and IgA binding to five cholera-specific antigens. Infection elicited stronger and broader antibody responses than vaccination, with rises in cholera toxin B-subunit (CTB) and toxin-coregulated pilus A (TcpA) antibodies uniquely associated with infection. Previously proposed random forest models frequently misclassified vaccinated individuals as recently infected (over 20% at some time points) during the first four months post-vaccination. To address this, we developed new random forest models incorporating vaccinee data, which kept false positive rates among vaccinated (1%) and unvaccinated (4%) individuals low without a significant loss in sensitivity. Simulated serosurveys demonstrated that unbiased seroincidence estimates could be achieved within 21 days of vaccination campaigns by ascertaining vaccination status of participants or applying updated models. These approaches to overcome biases in serological surveillance enable reliable seroincidence estimation even in areas with recent vaccination campaigns enhancing the utility of serological surveillance as an epidemiologic tool in moderate-to-high cholera incidence settings.\n                <\/jats:p>\n                <jats:sec>\n                  <jats:title>Significance statement<\/jats:title>\n                  <jats:p>Serological surveillance can improve how we monitor cholera in high burden areas where clinical surveillance is limited. However, vaccination can produce immune responses similar to infection, leading to overestimates in seroincidence. This study extends seroincidence estimation techniques using machine learning models to partially vaccinated populations. We analyzed antibody dynamics from vaccinated and infected individuals to develop methods that reduce misclassification of vaccinated individuals as recently infected. These methods enable reliable seroincidence estimates in areas with recent vaccination campaigns, providing a step toward better epidemiologic monitoring in the context of global cholera control initiatives.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2025.03.09.25323598","type":"posted-content","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T12:53:08Z","timestamp":1741870388000},"source":"Crossref","is-referenced-by-count":0,"title":["Expanding cholera serosurveillance to vaccinated populations"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0914-6722","authenticated-orcid":false,"given":"Forrest K.","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3755-4763","authenticated-orcid":false,"given":"Taufiqur R.","family":"Bhuiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1115-0894","authenticated-orcid":false,"given":"Damien M.","family":"Slater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Ternier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kian Robert","family":"Hutt Vater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashraful I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahima","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennia","family":"Visieres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajib","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Kamruzzaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0169-394X","authenticated-orcid":false,"given":"Edward T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-7153","authenticated-orcid":false,"given":"Stephen B.","family":"Calderwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4558-0339","authenticated-orcid":false,"given":"Regina C.","family":"LaRocque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-1849","authenticated-orcid":false,"given":"Richelle C.","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8401-0801","authenticated-orcid":false,"given":"Daniel T.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9741-8109","authenticated-orcid":false,"given":"Justin","family":"Lessler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-9230","authenticated-orcid":false,"given":"Louise C.","family":"Ivers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8928-9888","authenticated-orcid":false,"given":"Firdausi","family":"Qadri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8662-9077","authenticated-orcid":false,"given":"Andrew S.","family":"Azman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025032002580776000_2025.03.09.25323598v1.1","unstructured":"Roadmap 2030. Available at: https:\/\/www.gtfcc.org\/about-gtfcc\/roadmap-2030\/ [Accessed 25 October 2021]."},{"key":"2025032002580776000_2025.03.09.25323598v1.2","doi-asserted-by":"crossref","first-page":"e1003003","DOI":"10.1371\/journal.pmed.1003003","article-title":"The projected impact of geographic targeting of oral cholera vaccination in sub-Saharan Africa: A modeling study","volume":"16","year":"2019","journal-title":"PLoS Med"},{"key":"2025032002580776000_2025.03.09.25323598v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30359-6"},{"key":"2025032002580776000_2025.03.09.25323598v1.4","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3201\/eid2206.151592","article-title":"Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014","volume":"22","year":"2016","journal-title":"Emerg. Infect. Dis"},{"key":"2025032002580776000_2025.03.09.25323598v1.5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiab418"},{"key":"2025032002580776000_2025.03.09.25323598v1.6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-02810-4"},{"key":"2025032002580776000_2025.03.09.25323598v1.7","doi-asserted-by":"crossref","unstructured":"A. S. Azman , et al., Estimating cholera incidence with cross-sectional serology. Sci. Transl. Med. 11 (2019).","DOI":"10.1126\/scitranslmed.aau6242"},{"key":"2025032002580776000_2025.03.09.25323598v1.8","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.05615-11"},{"key":"2025032002580776000_2025.03.09.25323598v1.9","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00378-14"},{"key":"2025032002580776000_2025.03.09.25323598v1.10","unstructured":"Shortage of cholera vaccines leads to temporary suspension of two-dose strategy, as cases rise worldwide. Available at: https:\/\/www.who.int\/news\/item\/19-10-2022-shortage-of-cholera-vaccines-leads-to-temporary-suspension-of-two-dose-strategy--as-cases-rise-worldwide [Accessed 9 November 2024]."},{"key":"2025032002580776000_2025.03.09.25323598v1.11","doi-asserted-by":"crossref","first-page":"A132","DOI":"10.1016\/j.vaccine.2019.08.086","article-title":"Global oral cholera vaccine use, 2013\u20132018","volume":"38","year":"2020","journal-title":"Vaccine"},{"key":"2025032002580776000_2025.03.09.25323598v1.12","doi-asserted-by":"crossref","first-page":"e0190022","DOI":"10.1128\/mbio.01900-22","article-title":"Identifying Recent Cholera Infections Using a Multiplex Bead Serological Assay","volume":"13","year":"2022","journal-title":"MBio"},{"key":"2025032002580776000_2025.03.09.25323598v1.13","doi-asserted-by":"crossref","unstructured":"L. M. Mayo-Smith , et al., The Live Attenuated Cholera Vaccine CVD 103-HgR Primes Responses to the Toxin-Coregulated Pilus Antigen TcpA in Subjects Challenged with Wild-Type Vibrio cholerae. Clin. Vaccine Immunol. 24 (2017).","DOI":"10.1128\/CVI.00470-16"},{"key":"2025032002580776000_2025.03.09.25323598v1.14","doi-asserted-by":"crossref","first-page":"e0218033","DOI":"10.1371\/journal.pone.0218033","article-title":"Safety and immunogenicity of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine in adults and children in Vellore, South India","volume":"14","year":"2019","journal-title":"PLoS One"},{"key":"2025032002580776000_2025.03.09.25323598v1.15","unstructured":"WHO prequalifies new oral simplified vaccine for cholera. Available at: https:\/\/www.who.int\/news\/item\/18-04-2024-who-prequalifies-new-oral-simplified-vaccine-for-cholera [Accessed 27 May 2024]."},{"key":"2025032002580776000_2025.03.09.25323598v1.16","doi-asserted-by":"crossref","unstructured":"Q. Zheng , et al., Cholera outbreaks in sub-Saharan Africa during 2010-2019: A Descriptive Analysis. bioRxiv (2021).","DOI":"10.1101\/2021.10.25.21265347"},{"key":"2025032002580776000_2025.03.09.25323598v1.17","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.1993.1209"},{"key":"2025032002580776000_2025.03.09.25323598v1.18","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1093\/cid\/cix1039","article-title":"Immunogenicity and protection from a single dose of internationally available killed oral cholera vaccine: A systematic review and metaanalysis","volume":"66","year":"2018","journal-title":"Clin. Infect. Dis"},{"key":"2025032002580776000_2025.03.09.25323598v1.19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.22-0462","article-title":"An age-stratified, randomized immunogenicity trial of killed oral cholera vaccine with delayed second dose in Cameroon","volume":"107","year":"2022","journal-title":"Am. J. Trop. Med. Hyg"},{"key":"2025032002580776000_2025.03.09.25323598v1.20","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00037-12"},{"key":"2025032002580776000_2025.03.09.25323598v1.21","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00647-15"},{"key":"2025032002580776000_2025.03.09.25323598v1.22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.vaccine.2021.12.015","article-title":"A non-inferiority trial comparing two killed, whole cell, oral cholera vaccines (Cholvax vs. Shanchol) in Dhaka, Bangladesh","volume":"40","year":"2022","journal-title":"Vaccine"},{"key":"2025032002580776000_2025.03.09.25323598v1.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007057"},{"key":"2025032002580776000_2025.03.09.25323598v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(20)30310-7"},{"key":"2025032002580776000_2025.03.09.25323598v1.25","doi-asserted-by":"crossref","unstructured":"E. T. Ryan , et al., Systemic, Mucosal, and Memory Immune Responses following Cholera. Tropical Medicine and Infectious Disease 6, 192 (2021).","DOI":"10.3390\/tropicalmed6040192"},{"key":"2025032002580776000_2025.03.09.25323598v1.26","doi-asserted-by":"crossref","unstructured":"R. C. Kauffman , et al., Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells. MBio 7 (2016).","DOI":"10.1128\/mBio.02021-16"},{"key":"2025032002580776000_2025.03.09.25323598v1.27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix253"},{"key":"2025032002580776000_2025.03.09.25323598v1.28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57876-0"},{"key":"2025032002580776000_2025.03.09.25323598v1.29","doi-asserted-by":"crossref","unstructured":"C. Ritz , S. M. Jensen , D. Gerhard , J. C. Streibig , Dose-Response Analysis Using R (CRC Press, 2019).","DOI":"10.1201\/b21966"},{"key":"2025032002580776000_2025.03.09.25323598v1.30","unstructured":"RStan. Stan. Available at: https:\/\/mc-stan.org\/users\/interfaces\/rstan [Accessed 27 May 2024]."},{"key":"2025032002580776000_2025.03.09.25323598v1.31","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v031.i10"},{"key":"2025032002580776000_2025.03.09.25323598v1.32","unstructured":"S. Ashkiani , Dimensionality reduction and data visualization using MDS-SMACOF package in R. Available at: https:\/\/rstudio-pubs-static.s3.amazonaws.com\/246348_b31bca1e4be04bb395825dc6a00de364.html [Accessed 23 February 2022]."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.03.09.25323598","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:30:22Z","timestamp":1768509022000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.03.09.25323598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":32,"URL":"https:\/\/doi.org\/10.1101\/2025.03.09.25323598","relation":{},"subject":[],"published":{"date-parts":[[2025,3,11]]},"subtype":"preprint"}}